Sprinter Health, a healthcare startup revolutionizing home-based clinical and diagnostic services, has successfully closed its Series B funding round. The financing was led by venture capital firm General Catalyst, and included participation from heavyweights in the technology and healthcare investment sectors—Andreessen Horowitz, Google Ventures (GV), Accel, and the Regents of the University of California.
The funding will enable Sprinter Health to expand its reach and accelerate technological advancements in its offerings. The company specializes in providing on-demand, at-home medical care, including lab draws, COVID-19 and flu testing, vital checks, and other diagnostic services typically conducted in clinical settings. These services are facilitated by a team of ‘Sprinters,’ trained medical professionals who visit patients at their homes equipped with the tools and technology needed for care delivery.
In the wake of a growing demand for more accessible, patient-centric healthcare, Sprinter Health has emerged as a prominent innovator. By bridging the gap between telemedicine and traditional in-clinic appointments, the company aims to reduce healthcare barriers for patients with mobility challenges, busy schedules, or limited access to local healthcare providers.
The new round of funding underscores growing confidence in Sprinter Health’s model and its potential to impact the broader healthcare ecosystem. With support from a robust investor syndicate, Sprinter Health is poised to scale operations, enhance its workforce, and invest in data infrastructure to further improve clinical accuracy and patient outcomes.
This investment round places Sprinter Health among a growing group of startups attracting significant capital to transform the U.S. healthcare system through digital and home-based solutions.
Source: https:// – Courtesy of the original publisher.
